BOSTON SCIENTIFIC CORPORATION for BOSTON SCIENTIFIC CORPORATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S.17, the Medical Device and Innovation Protection Act - a bill to repeal the medical device tax S. 262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act - a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R.488, Save Our Medical Devices Act of 2011 - a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011 - a bill to extend the research credit through 2012 S.239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of hte alternative simplified research tax credit and makes such credit permanent Corporate tax reform - specifically the treatment of international earnings including the Chairman's International Tax Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDA BECKER | — |
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
Health Issues HCR
Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination H.R. 5651 - Food and Drug Administration Reform Act 2012 - A bill to renew the FDA User Fee program and to reform the medical device review program. S. 3187 - FDA Safety and Innovation Act - A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. Senate draft legislation to establish a national track and trace system for pharmaceuticals, specifically relating to convenience kits
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDA BECKER | — |
| KRISTEN HEDSTROM | — |
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
Budget/Appropriations BUD
Appropriations for pain management awareness programs H.R. 5973 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 S. 2375 Agriculture, Rural Development, FDA & Related Agencies Appropriations Act 2013 H.J. Res. 117 - Continuing Appropriations Act - provisions related to user fees for FDA
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
Education EDU
S. 758, A bill to establish a Science, Technology, Engineering and Math (STEM) Master Teacher Corps program S. 716, Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 3373 - STEM Education innovation Act - to promote STEM education H.R. 6517 - The STEM Network Act - to promote STEM education
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
Computer Industry CPI
Cybersecurity - Provisions related to setting standards for information sharing between public and private entities regarding Cyber attacks
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDA BECKER | — |
| STEVEN NEIL LAPIERRE | — |
| MICHAEL MATTOON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.